2023
DOI: 10.3389/fendo.2023.1137456
|View full text |Cite
|
Sign up to set email alerts
|

Tumour microenvironment in pheochromocytoma and paraganglioma

Abstract: Pheochromocytomas and Paragangliomas (Pheo/PGL) are rare catecholamine-producing tumours derived from adrenal medulla or from the extra-adrenal paraganglia respectively. Around 10–15% of Pheo/PGL develop metastatic forms and have a poor prognosis with a 37% of mortality rate at 5 years. These tumours have a strong genetic determinism, and the presence of succinate dehydrogenase B (SDHB) mutations are highly associated with metastatic forms. To date, no effective treatment is present for metastatic forms. In ad… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 189 publications
(173 reference statements)
0
4
0
Order By: Relevance
“…Along with morphological studies, molecular genetic analysis is carried out (Gimenez‐Roqueplo et al, 2023; A. Snezhkina et al, 2022; A. V. Snezhkina et al, 2020). Currently, the role of the microenvironment in the progression and metastasis of malignant tumors is widely argued (Hanahan & Weinberg, 2011; Koontongkaew, 2013; Martinelli et al, 2023). Tumor commonly progresses changing cell functions in the microenvironment: fibroblasts acquire properties of immunosuppressors, macrophages acquire tumorogenic functions, lymphocytes are gradually reprogrammed, and can exhibit pro‐tumor activity, MCs can turn into powerful pro‐inflammatory cells that affect tumor progression (Ribatti, 2023; Zhang et al, 2023).…”
Section: Discussionmentioning
confidence: 99%
“…Along with morphological studies, molecular genetic analysis is carried out (Gimenez‐Roqueplo et al, 2023; A. Snezhkina et al, 2022; A. V. Snezhkina et al, 2020). Currently, the role of the microenvironment in the progression and metastasis of malignant tumors is widely argued (Hanahan & Weinberg, 2011; Koontongkaew, 2013; Martinelli et al, 2023). Tumor commonly progresses changing cell functions in the microenvironment: fibroblasts acquire properties of immunosuppressors, macrophages acquire tumorogenic functions, lymphocytes are gradually reprogrammed, and can exhibit pro‐tumor activity, MCs can turn into powerful pro‐inflammatory cells that affect tumor progression (Ribatti, 2023; Zhang et al, 2023).…”
Section: Discussionmentioning
confidence: 99%
“…Adrenal tumors (ATs) are a rare type of tumor that usually occurs in the cortex or medulla of the adrenal gland ( 1 ). Depending on their type and size, these tumors can be benign or malignant ( 2 ). ATs can cause many symptoms, including high blood pressure, palpitations, headaches, insomnia, anxiety, and obesity ( 3 ).…”
Section: Introductionmentioning
confidence: 99%
“…Approximately 80% of PPGLs are linked to genetic mutations, often indicating a genetic predisposition ( 2 , 8 ). Gene expression profiling enables the classification of PPGLs into three distinct clusters based on their molecular characteristics: the pseudohypoxia signaling cluster (Cluster-1), the kinase signaling cluster (Cluster-2), and the WNT signaling cluster (Cluster-3).…”
Section: Introductionmentioning
confidence: 99%
“…Cluster-3 is characterized by the activation of the WNT signaling pathway, potentially contributing to increased cellular proliferation and invasiveness. Notably, Cluster-3 accounts for approximately 5%-10% of PPGLs cases and also includes tumors with mutations in the CSDE1 and the MAML3 fusion genes ( 2 , 12 , 13 ). In the three clusters, Cluster 1 exhibits the most prominent risk of metastasis ( 9 ).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation